Continuous glucose monitoring has matured from a diabetes-management niche into a duopoly-scale device franchise generating well over $12B of combined annual Dexcom/Abbott revenue, and the next leg of growth runs through two genuinely unresolved bets: whether Medicare extends coverage to the ~12 million non-insulin Type 2 diabetics, and whether a still-small non-diabetic "wellness CGM" category becomes a durable consumer business rather than a well-funded niche.
📈 What changed: September 2026: MiniMed Group (MMED) posted its first quarterly report as a standalone company — Q1 FY2027 (ended July 31, 2026) net sales of $843M, up 16.6% reported/15.8% organi…
| Indicator | Score | Reading |
|---|---|---|
| Maturity higher is better · high confidence | 82/100 | Diabetes CGM device business is scaled and commodity-reimbursed; the non-diabetic wellness layer is early-commercial. |
| Evidence Strength higher is better · high confidence | 75/100 | Company disclosures and a regulator clearance anchor the core facts; GLP-1 cross-current evidence is still forming. |
| Commercial Proximity higher is better · high confidence | 78/100 | Recurring, reimbursed device revenue at scale now; the wellness/non-diabetic wedge is real but still small and unproven at scale. |
| Capital & Policy Support higher is better · high confidence | 57/100 | Existing Medicare/payer coverage is a real floor; the incremental non-insulin Type 2 expansion is proposed, not yet committed. |
| Crowding Risk lower is better · low confidence | 55/100 | Established growth-medtech ownership; not at AI-style extremes, but well covered and moderately valued. |
| Reflexivity Risk lower is better · high confidence | 50/100 | Large-cap duopoly is earnings-grounded; the private wellness layer is capital-markets dependent and narrative-sensitive. |
Every indicator score is computed by the Northstar engine from analyst-set ordinal bands — never hand-written, never stored.
The public page is the summary (backed by 18 cited sources). Full briefing — company map, catalysts, native signals and sources — is inside the app.
Open in the appStart free →The Northstar Signal — what moved across all 350+ themes and why, in your inbox. Free, no spam, one-click unsubscribe.